๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Lectin and serum-PSA interaction as a screening test for prostate cancer

โœ Scribed by Pranab S. Basu; Ramdhan Majhi; Sandip K. Batabyal

Book ID
108313623
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
108 KB
Volume
36
Category
Article
ISSN
0009-9120

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Evaluation of prostatic specific antigen
Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer
โœ Bernard Candas; Lionel Cusan; Jose-Luis Gomez; Pierre Diamond; Raul E. Suburu; J ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 341 KB ๐Ÿ‘ 2 views

## BACKGROUND. The 11,811 first visits and 46,751 annual follow-up visits performed since 1988 were analyzed in order to assess the efficacy of serum prostatic specific antigen (PSA) and digital rectal examination (DRE) for diagnosis of prostate cancer. METHODS. At first visit, screening included

PSA-based screening for prostate cancer
PSA-based screening for prostate cancer in asymptomatic younger males: Pilot study in blood donors
โœ Reissigl, A.; Pointner, J.; Horninger, W.; Strasser, H.; Mayersbach, P.; Klocker ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 182 KB ๐Ÿ‘ 2 views

## Background: The efficacy and success of a screening program for prostate cancer in young and healthy asymptomatic volunteers are described. ## Methods: In the present study, prostate specific antigen (psa) samples obtained from 2,272 males (aged 40-65 years) who donated blood at the local red

Evaluation of DNA flow cytometry as a sc
Evaluation of DNA flow cytometry as a screening test for bladder cancer
โœ Ralph W. Devere White; Arline D. Deltch ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 531 KB

At this present time, we feel that there is no role for DNA flow cytometry (FCM), or indeed DNA studies by any other method, to be used as a screening procedure for patients with no prior history of bladder cancer due to the high false-positive rate found when monitoring exfoliated urothelial cells.